[Pediatric cutaneous mastocytosis]

Area of Science:

• Dermatology
• Hematology
• Pediatrics

Background:

• Mastocytosis encompasses rare diseases defined by mast cell accumulation in various organs.
• These conditions are categorized into systemic (10%) and cutaneous (90%) forms.
• Cutaneous mastocytosis predominantly affects pediatric populations and typically resolves favorably over time.

Observation:

• Diagnostic criteria for cutaneous mastocytosis, in the absence of systemic signs, include Darier's sign and skin biopsy findings.
• Darier's sign is a key diagnostic indicator.
• Skin histology confirms the characteristic mast cell infiltration.

Findings:

• Cutaneous mastocytosis is the predominant form, accounting for 90% of cases.
• Pediatric patients with cutaneous mastocytosis generally experience a favorable prognosis.
• Systemic mastocytosis represents a smaller subset of cases (10%).

Implications:

• Early diagnosis of cutaneous mastocytosis is crucial for appropriate management.
• Preventive strategies, such as avoiding degranulation triggers, are essential.
• Symptomatic treatment, primarily using antihistamine agents, helps manage patient discomfort.